|
ACHL Achilles Therapeutics Plc 1830749 |
| Income Statement |
|
Net Income
|
d918877d6k
|
-16,380,000 |
| Balance Sheet |
|
Current Assets
|
117,817,000 |
|
Assets
|
131,186,000 |
|
Current Liabilities
|
14,295,000 |
|
Liabilities
|
15,711,000 |
|
Equity
|
115,475,000 |
|
Shares Out
|
41,088,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-34,813,000 |
|
Investing Cash Flow
|
-731,000 |
| Market Analysis |
Market Cap
|
29,120,860 |
|
Price
|
1.48 |
|
BVPS
|
2.81 |
|
PB
|
0.52 |
|
EPS
|
-1.61 |
|
PS
|
158.75 |
|
FCF
|
-35,544,000 |
|
| Earnings |
|
| Apr |
May |
Jun |
| 4/04 |
-0.46 |
5/08 |
-0.30 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ACHL documents filed with the SEC.
ACHL Filings
Clear
